U.S. Wound Care Market - By Product (Advanced Wound Dressing (Foam, Alginate), Surgical Wound Care, Traditional Wound Care, Therapy Devices, Biologics), Application (Chronic, Acute), End use (Hospital, Specialty Clinic, Homecare) – Forecast, 2023-2032
Report ID: GMI7555
|
Published Date: December 2023
|
Report Format: PDF
Download Free PDF
Buy Now
Immediate Delivery
$2,168 $2,550
15% off
$3,000 $3,750
20% off
$3,535 $5,050
30% off
Buy now
Premium Report Details
Base Year: 2022
Companies covered: 13
Tables & Figures: 111
Countries covered: 1
Pages: 125
Download Free PDF

U.S. Wound Care Market
Get a free sample of this reportGet a free sample of this report U.S. Wound Care Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
U.S. Wound Care Market Size
U.S. Wound Care Market size was valued at USD 8 billion in 2022 and is speculated to register over 14.5% CAGR from 2023 to 2032. Wound care dressings refer to material that is applied directly to a wound to facilitate the healing process and protect the injured area. The increasing incidence of burn injuries is one of the major factors driving the demand for wound care dressings.
For instance, according to the American Burn Association, an estimated 450,000 individuals are treated annually due to burns in the U.S. Furthermore, the growing prevalence of diabetes across the U.S. is a significant factor contributing to delayed wound healing. Moreover, in 2023, as per the Centers for Disease Control and Prevention (CDC), approximately 38.4 million people in the U.S. suffer from diabetes, which accounts for about 11.6% of the country’s population. Diabetic foot ulcers and pressure ulcers are a common complication and are a major cause of hospital admissions in people with diabetes. Thus, this growing prevalence of diabetes is anticipated to boost demand of wound care dressings.
COVID-19 Impact
The COVID-19 pandemic had a significant impact on the wound care market in the U.S. It caused disruptions to healthcare services, raised patient concerns about safety, caused problems in the supply chain, limited healthcare expenditures, and redirected resources towards COVID-19 research. As a result, the market had experienced a decline in procedures, which hampered its upward trajectory.
U.S. Wound Care Market Trends
The increasing prevalence of acute and chronic wounds is a significant concern in healthcare with its implications on the wound care market. These wounds can result from various causes including accidents, surgeries, chronic health conditions, and lifestyle factors. Chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, are particularly common.
U.S. Wound Care Market Analysis
The market by product is categorized into advanced wound dressing, surgical wound care, traditional wound care, wound therapy devices and wound care biologics. The advanced wound dressing segment garnered USD 2.3 billion revenue size in the year 2022.
Based on application, the U.S. wound care market is segmented into chronic and acute wounds. The chronic wounds segment is further bifurcated into diabetic foot ulcers, pressure ulcers, venous leg ulcers, and other chronic wounds. The acute wounds are subdivided into surgical wounds, trauma wounds, and burns. This segment garnered USD 4.5 billion revenue size in the year 2022.
Based on end-use, the U.S. wound care market is segmented into hospitals, specialty clinics, home care settings, and other end-users. The hospitals segment garnered USD 3 billion revenue size in the year 2022.
U.S. wound care market accounted for USD 8 billion revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline.
U.S. Wound Care Market Share
The U.S. wound care industry is consolidated, with key players including, Smith & Nephew, B. Braun Melsungen AG, and others dominating the market space. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market share. For instance, in September 2021, Omeza announced that the U.S. FDA had approved its Omeza collagen matrix. This matrix is made of hydrolyzed fish collagen and is used to treat chronic wounds such as diabetic ulcers, surgical wounds, and partial and full-thickness wounds.
Some of the eminent market participants operating in the U.S. wound care industry include:
U.S. Wound Care Industry News:
U.S. wound care market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product, 2018 – 2032 (USD Million)
By Application, 2018 – 2032 (USD Million)
By End-use, 2018 – 2032 (USD Million)